Cargando…
Synthesis of Novel Benzimidazole-Based Thiazole Derivatives as Multipotent Inhibitors of α-Amylase and α-Glucosidase: In Vitro Evaluation along with Molecular Docking Study
In this study, hybrid analogs of benzimidazole containing a thiazole moiety (1–17) were afforded and then tested for their ability to inhibit α-amylase and α-glucosidase when compared to acarbose as a standard drug. The recently available analogs showed a wide variety of inhibitory potentials that r...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9572811/ https://www.ncbi.nlm.nih.gov/pubmed/36234994 http://dx.doi.org/10.3390/molecules27196457 |
_version_ | 1784810709822996480 |
---|---|
author | Hussain, Rafaqat Iqbal, Shahid Shah, Mazloom Rehman, Wajid Khan, Shoaib Rasheed, Liaqat Rahim, Fazal Dera, Ayed A. Kehili, Sana Elkaeed, Eslam B. Awwad, Nasser S. Bajaber, Majed A. Alahmdi, Mohammed Issa Alrbyawi, Hamad Alsaab, Hashem O. |
author_facet | Hussain, Rafaqat Iqbal, Shahid Shah, Mazloom Rehman, Wajid Khan, Shoaib Rasheed, Liaqat Rahim, Fazal Dera, Ayed A. Kehili, Sana Elkaeed, Eslam B. Awwad, Nasser S. Bajaber, Majed A. Alahmdi, Mohammed Issa Alrbyawi, Hamad Alsaab, Hashem O. |
author_sort | Hussain, Rafaqat |
collection | PubMed |
description | In this study, hybrid analogs of benzimidazole containing a thiazole moiety (1–17) were afforded and then tested for their ability to inhibit α-amylase and α-glucosidase when compared to acarbose as a standard drug. The recently available analogs showed a wide variety of inhibitory potentials that ranged between 1.31 ± 0.05 and 38.60 ± 0.70 µM (against α-amylase) and between 2.71 ± 0.10 and 42.31 ± 0.70 µM (against α-glucosidase) under the positive control of acarbose (IC(50) = 10.30 ± 0.20 µM against α-amylase) (IC(50) = 9.80 ± 0.20 µM against α-glucosidase). A structure–activity relationship (SAR) study was carried out for all analogs based on substitution patterns around both rings B and C respectively. It was concluded from the SAR study that analogs bearing either substituent(s) of smaller size (−F and Cl) or substituent(s) capable of forming hydrogen bonding (−OH) with the catalytic residues of targeted enzymes enhanced the inhibitory potentials. Therefore, analogs 2 (bearing meta-fluoro substitution), 3 (having para-fluoro substitution) and 4 (with ortho-fluoro group) showed enhanced potency when evaluated against standard acarbose drug with IC(50) values of 4.10 ± 0.10, 1.30 ± 0.05 and 1.90 ± 0.10 (against α-amylase) and 5.60 ± 0.10, 2.70 ± 0.10 and 2.90 ± 0.10 µM (against α-glucosidase), correspondingly. On the other hand, analogs bearing substituent(s) of either a bulky nature (−Br) or that are incapable of forming hydrogen bonds (−CH(3)) were found to lower the inhibitory potentials. In order to investigate the binding sites for synthetic analogs and how they interact with the active areas of both targeted enzymes, molecular docking studies were also conducted on the potent analogs. The results showed that these analogs adopted many important interactions with the active areas of enzymes. The precise structure of the newly synthesized compounds was confirmed using several spectroscopic techniques as NMR and HREI-MS. |
format | Online Article Text |
id | pubmed-9572811 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-95728112022-10-17 Synthesis of Novel Benzimidazole-Based Thiazole Derivatives as Multipotent Inhibitors of α-Amylase and α-Glucosidase: In Vitro Evaluation along with Molecular Docking Study Hussain, Rafaqat Iqbal, Shahid Shah, Mazloom Rehman, Wajid Khan, Shoaib Rasheed, Liaqat Rahim, Fazal Dera, Ayed A. Kehili, Sana Elkaeed, Eslam B. Awwad, Nasser S. Bajaber, Majed A. Alahmdi, Mohammed Issa Alrbyawi, Hamad Alsaab, Hashem O. Molecules Article In this study, hybrid analogs of benzimidazole containing a thiazole moiety (1–17) were afforded and then tested for their ability to inhibit α-amylase and α-glucosidase when compared to acarbose as a standard drug. The recently available analogs showed a wide variety of inhibitory potentials that ranged between 1.31 ± 0.05 and 38.60 ± 0.70 µM (against α-amylase) and between 2.71 ± 0.10 and 42.31 ± 0.70 µM (against α-glucosidase) under the positive control of acarbose (IC(50) = 10.30 ± 0.20 µM against α-amylase) (IC(50) = 9.80 ± 0.20 µM against α-glucosidase). A structure–activity relationship (SAR) study was carried out for all analogs based on substitution patterns around both rings B and C respectively. It was concluded from the SAR study that analogs bearing either substituent(s) of smaller size (−F and Cl) or substituent(s) capable of forming hydrogen bonding (−OH) with the catalytic residues of targeted enzymes enhanced the inhibitory potentials. Therefore, analogs 2 (bearing meta-fluoro substitution), 3 (having para-fluoro substitution) and 4 (with ortho-fluoro group) showed enhanced potency when evaluated against standard acarbose drug with IC(50) values of 4.10 ± 0.10, 1.30 ± 0.05 and 1.90 ± 0.10 (against α-amylase) and 5.60 ± 0.10, 2.70 ± 0.10 and 2.90 ± 0.10 µM (against α-glucosidase), correspondingly. On the other hand, analogs bearing substituent(s) of either a bulky nature (−Br) or that are incapable of forming hydrogen bonds (−CH(3)) were found to lower the inhibitory potentials. In order to investigate the binding sites for synthetic analogs and how they interact with the active areas of both targeted enzymes, molecular docking studies were also conducted on the potent analogs. The results showed that these analogs adopted many important interactions with the active areas of enzymes. The precise structure of the newly synthesized compounds was confirmed using several spectroscopic techniques as NMR and HREI-MS. MDPI 2022-09-30 /pmc/articles/PMC9572811/ /pubmed/36234994 http://dx.doi.org/10.3390/molecules27196457 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Hussain, Rafaqat Iqbal, Shahid Shah, Mazloom Rehman, Wajid Khan, Shoaib Rasheed, Liaqat Rahim, Fazal Dera, Ayed A. Kehili, Sana Elkaeed, Eslam B. Awwad, Nasser S. Bajaber, Majed A. Alahmdi, Mohammed Issa Alrbyawi, Hamad Alsaab, Hashem O. Synthesis of Novel Benzimidazole-Based Thiazole Derivatives as Multipotent Inhibitors of α-Amylase and α-Glucosidase: In Vitro Evaluation along with Molecular Docking Study |
title | Synthesis of Novel Benzimidazole-Based Thiazole Derivatives as Multipotent Inhibitors of α-Amylase and α-Glucosidase: In Vitro Evaluation along with Molecular Docking Study |
title_full | Synthesis of Novel Benzimidazole-Based Thiazole Derivatives as Multipotent Inhibitors of α-Amylase and α-Glucosidase: In Vitro Evaluation along with Molecular Docking Study |
title_fullStr | Synthesis of Novel Benzimidazole-Based Thiazole Derivatives as Multipotent Inhibitors of α-Amylase and α-Glucosidase: In Vitro Evaluation along with Molecular Docking Study |
title_full_unstemmed | Synthesis of Novel Benzimidazole-Based Thiazole Derivatives as Multipotent Inhibitors of α-Amylase and α-Glucosidase: In Vitro Evaluation along with Molecular Docking Study |
title_short | Synthesis of Novel Benzimidazole-Based Thiazole Derivatives as Multipotent Inhibitors of α-Amylase and α-Glucosidase: In Vitro Evaluation along with Molecular Docking Study |
title_sort | synthesis of novel benzimidazole-based thiazole derivatives as multipotent inhibitors of α-amylase and α-glucosidase: in vitro evaluation along with molecular docking study |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9572811/ https://www.ncbi.nlm.nih.gov/pubmed/36234994 http://dx.doi.org/10.3390/molecules27196457 |
work_keys_str_mv | AT hussainrafaqat synthesisofnovelbenzimidazolebasedthiazolederivativesasmultipotentinhibitorsofaamylaseandaglucosidaseinvitroevaluationalongwithmoleculardockingstudy AT iqbalshahid synthesisofnovelbenzimidazolebasedthiazolederivativesasmultipotentinhibitorsofaamylaseandaglucosidaseinvitroevaluationalongwithmoleculardockingstudy AT shahmazloom synthesisofnovelbenzimidazolebasedthiazolederivativesasmultipotentinhibitorsofaamylaseandaglucosidaseinvitroevaluationalongwithmoleculardockingstudy AT rehmanwajid synthesisofnovelbenzimidazolebasedthiazolederivativesasmultipotentinhibitorsofaamylaseandaglucosidaseinvitroevaluationalongwithmoleculardockingstudy AT khanshoaib synthesisofnovelbenzimidazolebasedthiazolederivativesasmultipotentinhibitorsofaamylaseandaglucosidaseinvitroevaluationalongwithmoleculardockingstudy AT rasheedliaqat synthesisofnovelbenzimidazolebasedthiazolederivativesasmultipotentinhibitorsofaamylaseandaglucosidaseinvitroevaluationalongwithmoleculardockingstudy AT rahimfazal synthesisofnovelbenzimidazolebasedthiazolederivativesasmultipotentinhibitorsofaamylaseandaglucosidaseinvitroevaluationalongwithmoleculardockingstudy AT deraayeda synthesisofnovelbenzimidazolebasedthiazolederivativesasmultipotentinhibitorsofaamylaseandaglucosidaseinvitroevaluationalongwithmoleculardockingstudy AT kehilisana synthesisofnovelbenzimidazolebasedthiazolederivativesasmultipotentinhibitorsofaamylaseandaglucosidaseinvitroevaluationalongwithmoleculardockingstudy AT elkaeedeslamb synthesisofnovelbenzimidazolebasedthiazolederivativesasmultipotentinhibitorsofaamylaseandaglucosidaseinvitroevaluationalongwithmoleculardockingstudy AT awwadnassers synthesisofnovelbenzimidazolebasedthiazolederivativesasmultipotentinhibitorsofaamylaseandaglucosidaseinvitroevaluationalongwithmoleculardockingstudy AT bajabermajeda synthesisofnovelbenzimidazolebasedthiazolederivativesasmultipotentinhibitorsofaamylaseandaglucosidaseinvitroevaluationalongwithmoleculardockingstudy AT alahmdimohammedissa synthesisofnovelbenzimidazolebasedthiazolederivativesasmultipotentinhibitorsofaamylaseandaglucosidaseinvitroevaluationalongwithmoleculardockingstudy AT alrbyawihamad synthesisofnovelbenzimidazolebasedthiazolederivativesasmultipotentinhibitorsofaamylaseandaglucosidaseinvitroevaluationalongwithmoleculardockingstudy AT alsaabhashemo synthesisofnovelbenzimidazolebasedthiazolederivativesasmultipotentinhibitorsofaamylaseandaglucosidaseinvitroevaluationalongwithmoleculardockingstudy |